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Introduction
Tuberculosis (TB) is an infectious disease caused by 
members of the Mycobacterium tuberculosis complex.[1,2] 
About a third of the world’s population is estimated to 
be infected with the disease causing organisms, while 
the lifetime risk of developing the disease is 5–10%.[3] 
In Nigeria, the majority of TB infections are caused by 
M. tuberculosis followed by M. africanum, and M. bovis;[4] 
and most importantly, the burden of the disease is the 
highest in Africa.[5,6] Furthermore, the global effort at 
controlling the disease through the Stop TB initiative has 
been seriously challenged by the human immunodeficiency 
virus (HIV) pandemic in developing countries. This is 
because, TB is associated with HIV infection; HIV-positive 
individuals are about 20 to 37 times more likely to develop 
TB when compared to HIV-negative individuals.[6] 
Likewise, a TB patient who is coinfected with HIV (TB/
HIV) is more likely to die, and when sputum positive 
(ss+), is more likely to transmit the infection. In view 
of the above public health issues and the fact that the 
protocol for TB/HIV treatment varies from that of a TB 
case without HIV,[7,8] it becomes very important to screen 
TB patients for HIV.
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Background: The prevalence of HIV in Enugu State is the highest in Southeastern Nigeria. Since HIV is associated 
with TB, it is important to assess the performance of the Enugu State TB program as regards HIV screening of TB 
cases. This study assesses the proportions of TB cases that are screened for HIV as well as the prevalence of HIV 
among individuals with TB at the Enugu State TB program of Nigeria.
Materials and Methods: The study was a retrospective review of data from the Enugu State TB program, Nigeria, from 
2008 to 2009. Analysis was both descriptive and inferential at 95% confidence levels.
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Nigeria ranks top in Africa with respect to the burden 
of both TB and HIV infections. In 2007, the estimated 
proportion of TB cases that were coinfected with HIV 
was 27%.[6] On the other hand, Enugu State of Nigeria 
has the highest HIV prevalence in the southeastern 
geopolitical zone of the country.[9] It is therefore likely 
that the TB/HIV prevalence in the State is equally high 
which calls for a special effort at screening for HIV among 
individuals with TB and vice versa. It has been observed 
that all cases of TB were not screened for HIV at the 
TB treatment sites in the State, unlike in the adult HIV 
treatment sites where TB screening is part of the routine 
investigations carried out after diagnosis of HIV. It became 
important to assess the performance of the State’s TB 
program as regards HIV screening of reported TB cases.
The study was designed to determine the proportions of 
cohorts of TB cases that were screened for HIV at the 
Enugu State TB program, Nigeria, and the prevalence of 
HIV among individuals diagnosed with TB in the program. 
It is hoped that the study findings would assist both the 
National and Enugu State TB programs in their efforts at 
rendering quality services to TB patients.
Materials and Methods
The study was a retrospective review of unpublished 
secondary data of all patients registered under the TB control 
program of the Ministry of health, Enugu State, Nigeria 
covering the 2-year period from 2008 to 2009. It was carried 
out over a 3-month period of March to May 2010. The data 
source was the annual registration (cohorts) of TB from 
all the Directly Observed Therapy Short course (DOTS) 
centers in the State – for the purpose of this study, a cohort 
means a group of TB patient diagnosed and registered for a 
specified 1-year period.[10] Variables of interest were patients’ 
disease category, age, sex, HIV screening status, and results. 
There were no data on TB/HIV for the period prior to 2008.
The Enugu State TB control program utilizes the serial rapid 
antibody testing which involves the use of two sequential 
HIV antibody tests. The second test is offered to a client 
only when the first test is positive.
Data analysis was done with Microsoft Excel software 
while data presentations were basically descriptive using 
tables and chart. However, Epi Info software version 3.5.1 
was used where applicable for inferential statistics at 95% 
confidence level, and results were expressed using odd 
ratios (OR) and P values. A P value <0.05 was considered 
statistically significant.
The TB control activities in Nigeria are coordinated by 
the National Tuberculosis and Leprosy Control Programme 
(NTBLCP)
The detailed structure of the National Tuberculosis Control 
Programme and the current definitions for categories of 
registered sputum smear positive TB patients in Nigeria 
have been described in related publications.[11,12]
Enugu State is one of the five states in the southeastern 
zone of the country. It has an approximate land mass of 
8,727.1 km2. The State capital is Enugu which is about 
5 hours drive from Abuja, the capital of Nigeria. The most 
recent census figure for the State was 3,257,298 million.[13] 
and the estimated population growth rate is 2.28%.[14] About 
95% of the State’s population are ethnic Igbos and most of 
the existing 17 LGAs are rural with majority of the working 
population being farmers and petty traders.[14] The health 
care services in the State are delivered by both private and 
government (public) health facilities. The latter includes 
the primary health care (PHC) facilities which are the 
operational sites of the DOTS. The State has DOTS services 
in all the 17 LGAs of the state with a total of 95 functional 
DOTS and 30 microscopy centers.[11]
Results
For the 2-year period under review, a total of 3,286 all-TB 
cases were registered in Enugu State of Nigeria which 
included 1,602 cases in 2008 and 1,684 cases in 2009. Out of 
these, 2,797 (85.1%) patients were new cases of pulmonary 
tuberculosis which included 1,867 (56.8%) new ss+ cases 
and 930 (28.3%) new sputum smear negative (ss-) cases. 
There were 286 (8.7%) extrapulmonary cases while the 
remaining 6.2% of all cases were made up of relapse, failure, 
return after default, and others. Nine hundred and sixty five 
(60.2%) new ss+ cases were registered in the year 2008 
which consisted of 532 (55.1%) and 433 (44.9) females. 
For year 2009, a total of 902 (53.6%) new ss+ cases were 
registered – 478 (53.0%) males and 424 (47.0%) females. 
For both cohorts of new ss+ cases, the 25- to –34-year age 
group had the highest burden of TB (18.2%) while the 0- to 
14-year age group had the least number of cases (1.8%). 
In general, the proportion of new ss+ male cases (54.1%) 
registered within the study period was higher than that of 
females (45.9%).
One thousand one hundred and forty four (67.9%) of 
all-TB cases were screened for HIV in the year 2009, 
while 1,264 (78.9%) were screened in 2008. The observed 
decrease in screening rate was statistically significant 
[P<0.001, OR=0.57 (95% CI: 0.48, 0.67)]. Likewise, the 
749 (83.0%) of new ss+ TB cases screened for HIV in the 
year 2009, was significantly lower than the 848 (87.9%) 
screened in 2008 [P<0.003, OR=0.68 (95% CI: 0.52, 
0.88)] [Table 1 and Figure 1].
Out of all TB cases tested for HIV each year, 411 (32.5%) 
and 414 (36.2%) cases were HIV positive in 2008 and 2009 
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respectively. The observed difference was not statistically 
significant [P<0.059, OR=1.18 (95% CI: 0.99, 1.40]. 
Similar prevalence figures were also observed for new ss+ 
cases [Table 2 and Figure 1]. In all, the mean prevalence of 
HIV for all TB cases over the 2-year period was 34.4%, while 
that of the new ss+ PTB was 30.7%. Also, the prevalence of 
HIV among all TB cases and new ss+ PTB cases were higher 
in 2009 when compared to their corresponding values in 
2008. Details of the prevalence of HIV infection among TB 
cohorts in Enugu State are shown in Table 2.
Discussion
In this study, the male gender and the 25- to 34-year age 
group bore the greatest burden of TB, which is consistent 
with the current epidemiology of the disease.[6] Considering 
the Nigerian national TB case detection rate of about 
30%,[11] it is most probable that the total number of TB 
cases registered in the Enugu State TB program during 
the study period was just a tip of the ice berg, which 
calls for a more active case detection strategy. The mean 
TB/HIV prevalence of over 30% identified in this study 
was higher than the Nigerian national estimate of 27%.[6] 
This observation may not be surprising because of the fact 
that Enugu State has the highest HIV prevalence in the 
southeastern zone of Nigeria.[9] This equally underscores 
the special need to ensure that all TB cases are tested for 
HIV so as to optimize their care. Furthermore, for those TB 
cases that were not tested for HIV, the likely scenario was 
that the prevalence of TB/HIV among them might be similar 
to the observed figures with its attendant implications on 
public health and patient management. For instance, it 
has been established that an active TB case that tested 
positive to HIV should commence anti-TB, after which an 
appropriate antiretroviral regime is commenced as soon as 
possible within 8 weeks.[8] In view of the above scenario, it 
becomes more worrisome that the proportion of both all TB 
and new ss+ cases tested HIV in 2009, in the Enugu State 
TB program of Nigeria, was significantly lower than the 
preceding 2008 [Table 1]. This declining uptake may suggest 
program failure in that regard which should demand an 
urgent reevaluation of the program strategy and monitoring.
Screening for HIV could be client initiated – voluntary 
counseling and testing (VCT) or provider initiated – provider 
initiated HIV counseling and testing (PIHTC).[15] Thus, 
the latter has three approaches – mandatory, opt-in, and 
opt-out. The mandatory approach makes HIV testing 
compulsory for all patients thus raising human right issues; 
it is therefore not encouraged. On the other hand, both 
opt-in and opt-out approaches involve pretest information 
which should include the patient’s information on his/her 
right to decline the test. However, in the opt-in approach, 
the patient should explicitly consent to HIV testing before 
it could be carried out, while in the opt-out approach, 
the patient “must specifically decline the HIV testing if 
s/he does not want it performed.”[15] The National TB 
program of Nigeria recommends PIHTC but was not 
Table 1: Proportion of TB cases tested for HIV in Enugu State, Nigeria
TB category TB cohort (year) No of cases HIV tested (%) P value OR (95% CI)
Yes No 
All TB 2009 1,684 1,144 (67.9) 540 (32.1) <0.001 0.57 (0.48 - 0.67)
2008 1,602 1,264 (78.9) 338 (21.1) - -
Total 3,286 2,408 (73.3) 878 (26.7)
New ss+ TB 2009 902 749 (83.0) 153 (17.0) 0.003 0.68 (0.52 - 0.88)
2008 965 848 (87.9) 117 (12.1) - -
Total 1,867 1,597 (85.5) 270 (14.5)
Table 2: Prevalence of TB / HIV in Enugu State, Nigeria
Year 2008 Year 2009 Mean TB/HIV (%) P-value OR (95% CI)
HIV+ve (all TB) 411 (32.5)a 414 (36.2)a 34.5 0.059 1.18 (0.99--1.40)
HIV+ve (new ss+) 258 (30.4)b 232 (31.0)b 30.7 0.812 1.03 (0.82--1.28)
aDenominator = all TB cases tested for HIV.; bDenominator = new ss+ cases tested for HIV.
Figure 1: Graphical representation of HIV screening, in TB 
program of Enugu State, Nigeria
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explicit on the approach.[7] However, a critical look at 
the steps outlined in the program’s manual especially the 
“confirmation of willingness of patient to proceed with test 
and seek informed consent”[7] suggests that the National 
program recommends the opt-in approach. Unfortunately, 
suboptimal yield of similar protocols have been reported 
from other developing countries.[16,17] Therefore, the use 
of the opt-in approach of PIHTC in the Enugu State TB 
program may be contributing to the increasing unmet HIV 
testing need within the program. This assumption may also 
hold for the national TB program where only 62.2% of TB 
patients were tested for HIV in 2008.[11] The experience 
from cervical cancer screening in Nigeria suggests that the 
awareness of a preventable disease may not translate to its 
improved screening.[18] Therefore, some form of “prompting” 
has been recommended to overcome the inertia and 
fear that might delay or prevent the screening of at-risk 
individuals; the “opt-out” approach is believed to provide 
this “prompting.”[19]
It is therefore recommended that the Enugu State TB 
program should scale up its HIV screening by adopting 
the opt-out approach of PIHTC and improve its program 
monitoring in the area of HIV screening. This suggestion 
if adopted should go with staff retraining so as to ensure 
effective implementation. Because the NTBLCP workers’ 
manual is used by all State TB programs in Nigeria, the 
above recommendation may apply to the national TB 
control program.
This study was limited by its reliance on “cleaned” data from 
the Enugu State TB program. Nevertheless, the validity of the 
data is not in doubt and the study’s results were unlikely 
to have been affected. It was also not possible to study the 
effect of patients’ demographic and other variables such 
as educational status on HIV screening status and results. 
Furthermore, the study recognizes other possible impediments 
to HIV screening in our environment including funding and 
availability of test kits, which might have contributed to the 
declining uptake of HIV screening in the program.
It is concluded that TB/HIV prevalence in Enugu State 
of Nigeria is very high. The performance of the State’s 
TB program with respect to HIV testing of TB patients 
was not only suboptimal but it also declined significantly 
in 2009 when compared to 2008. The adoption of the 
“opt-out” approach of PIHTC as well as improved program 
monitoring, by the State’s TB program, may help to scale 
up the HIV testing among TB patients.
References
1. Boulahbal F, Heifets L. Bacteriology of tuberculosis. In: Raviglione MC, editor. 
Reichman and Hershfield’s Tuberculosis: A Comprehensive, International 
Approach Part A. 3rd ed. New York: Informa Healthcare USA Inc; 2006. 
p. 29-46.
2. Grange J. Mycobacterium tuberculosis: The organism. In: Davies PD, Barnes PF, 
Gordon SB, editors. Clinical Tuberculosis. 4th ed. London: Hodder and 
Stoughton Ltd; 2008. p. 65-78.
3. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. 
The growing burden of tuberculosis: Global trends and interactions with the 
HIV epidemic. Arch Intern Med 2003;163:1009-21.
4. Cadmus S, Palmer S, Okker M, Dale J, Gover K, Smith N, et al. Molecular 
analysis of human and bovine tubercle bacilli from a local setting in Nigeria. 
J Clin Microbiol 2006;44:29-34.
5. Kaiser Family Foundation. Global Health Facts: People Living with TB 2008. 
Available from: http://www globalhealthfacts org/topic jsp?i=16. [Last accessed 
on 2010 Apr 14].
6. WHO. Global tuberculosis control: Epidemiology, strategy, financing: 
WHO report 2009. Avai lable from: http://whqlibdoc who int/
publications/2009/9789241563802_eng pdf. [Last accessed on 2010 Apr 7].
7. Adamu I, Adelusi A, Adesigbin O, Agborubere D, Alabi GA, Aribisala P. National 
Tuberculosis and Leprosy Control Programme: Workers’ manual. 5th ed. Abuja: 
FMOH; 2008.
8. WHO. Treatment of tuberculosis: Guidelines. 4th ed. Geneva: WHO Press; 2010. 
Available from: http://whqlibdoc who int/publications/2010/9789241547833_
eng pdf. [Last accessed 2010 Apr 7].
9. Nigeria Federal Ministry of Health (FMOH). Technical Report on 2005 National 
HIV/Syphilis Sero-prevalence Sentinel Survey. Abuja: FMOH; 2006.
10. WHO, International Union against Tuberculosis and Lung Disease, Royal 
Netherlands Tuberculosis Association. Revised international definitions in 
tuberculosis control. Int J Tuberc Lung Dis 2001;5:213-5
11. Nigeria FMOH. National Tuberculosis and Leprosy Control Programme: 
Annual report 2008. Abuja: FMOH; 2009.
12. Dim CC, Dim NR, Morkve O. Tuberculosis: A review of current concepts and 
control programme in Nigeria. Niger J Med 2011;20:200-6.
13. National Population Commisison of Nigeria. REPORT ON THE FINAL 2006 
CENSUS RESULTS: National, State and Local Government Area Population 
figures. Available from: http://www population gov ng/2006_final_results/
enugufinal pdf. [Last accessed on 2010 Apr 14].
14. Chukwuani CM, Olugboji A, Akuto EE, Odebunmi A, Ezeilo E, Ugbene E. 
A baseline survey of the Primary Healthcare system in south eastern Nigeria. 
Health Policy 2006;77:182-201.
15. WHO. Guidance on provider-initaited HIV testing and counselling in health 
facilities. Switzerland: WHO, 2007. Available from: http://www.who.int/hiv/pub/
guidelines/9789241595568_en.pdf. [Last accessed on 2010 Apr 7].
16. Jerene D, Endale A, Lindtjorn B. Acceptability of HIV counselling and testing 
among tuberculosis patients in south Ethiopia. BMC Int Health Hum Rights 
2007;7:4.
17. Thomas BE, Ramachandran R, Anitha S, Swaminathan S. Feasibility of routine 
HIV testing among TB patients through a voluntary counselling and testing 
centre. Int J Tuberc Lung Dis 2007;11:1296-301.
18. Dim CC, Ekwe E, Madubuko T, Dim NR, Ezegwui HU. Improved awareness of 
Pap smear may not affect its use in Nigeria: A case study of female medical 
practitioners in Enugu, southeastern Nigeria. Trans R Soc Trop Med Hyg 
2009;103:852-4.
19. Dim CC, Nwagha UI, Ezegwui HU, Dim NR. The need to incorporate routine 
cervical cancer counselling and screening in the management of women at 
the outpatient clinics in Nigeria. J Obstet Gynaecol 2009;29:754-6
How to cite this article: ???
Source of Support: Nil, Conflict of Interest: None declared.
